(Q44852799)

6 December 2017

A pilot study of serum microRNA signatures as a novel biomarker for occult hepatitis B virus infection (English)

1 reference

6 December 2017

0 references

1 reference

1 reference

Yuanyuan Chen

1

1 reference

6 December 2017

Limin Li

2

1 reference

6 December 2017

Zhenxian Zhou

3

1 reference

6 December 2017

Nan Wang

4

1 reference

6 December 2017

Chen-Yu Zhang

5

1 reference

6 December 2017

Ke Zen

6

1 reference

6 December 2017

6 March 2012

1 reference

Medical Microbiology and Immunology

6 December 2017

1 reference

6 December 2017

201

1 reference

6 December 2017

3

1 reference

6 December 2017

389-395

1 reference

https://scigraph.springernature.com/pub.10.1007/s00430-011-0223-0

6 December 2017

0 references

cites work

Impact of hepatitis B virus surface protein mutations on the diagnosis of occult hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1007%2FS00430-011-0223-0

Prevalence of occult hepatitis B infection in a highly endemic area for chronic hepatitis B: a study of a large blood donor population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-011-0223-0

Occult hepatitis B: clinical implications and treatment decisions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-011-0223-0

Transfusion-transmitted hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-011-0223-0

A 2010 update on occult hepatitis B infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-011-0223-0

Statements from the Taormina expert meeting on occult hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-011-0223-0

The characteristics of the cell-mediated immune response identify different profiles of occult hepatitis B virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-011-0223-0

MicroRNAs as potential agents to alter resistance to cytotoxic anticancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-011-0223-0

microRNAs as oncogenes and tumor suppressors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-011-0223-0

MicroRNA in cancer prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-011-0223-0

MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-011-0223-0

Emerging role of miR-106b-25/miR-17-92 clusters in the control of transforming growth factor beta signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-011-0223-0

The functions of animal microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-011-0223-0

MicroRNAs-372/373 promote the expression of hepatitis B virus through the targeting of nuclear factor I/B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-011-0223-0

Modulation of hepatitis B virus replication and hepatocyte differentiation by MicroRNA-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-011-0223-0

Differential microRNA expression between hepatitis B and hepatitis C leading disease progression to hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-011-0223-0

Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-011-0223-0

Expression profile of microRNAs in serum: a fingerprint for esophageal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-011-0223-0

Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-011-0223-0

Serum microRNA profiles serve as novel biomarkers for HBV infection and diagnosis of HBV-positive hepatocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-011-0223-0

Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-011-0223-0

The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-011-0223-0

Serum microRNAs are promising novel biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-011-0223-0

Circulating microRNAs as stable blood-based markers for cancer detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-011-0223-0

Plasma and synovial fluid microRNAs as potential biomarkers of rheumatoid arthritis and osteoarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-011-0223-0

Rapid and specific genotyping system for hepatitis B virus corresponding to six major genotypes by PCR using type-specific primers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-011-0223-0

The let-7 family of microRNAs inhibits Bcl-xL expression and potentiates sorafenib-induced apoptosis in human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-011-0223-0

Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-011-0223-0

Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-011-0223-0

Positive and negative modulation of viral and cellular mRNAs by liver-specific microRNA miR-122.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-011-0223-0

miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-011-0223-0

MicroRNA-23b cluster microRNAs regulate transforming growth factor-beta/bone morphogenetic protein signaling and liver stem cell differentiation by targeting Smads.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-011-0223-0

microRNAs and the immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-011-0223-0

MicroRNA-mediated control of cell fate in megakaryocyte-erythrocyte progenitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-011-0223-0

miR-150, a microRNA expressed in mature B and T cells, blocks early B cell development when expressed prematurely

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-011-0223-0

MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-011-0223-0

Occult hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-011-0223-0

Hepatitis B virus and hepatitis C virus co-infection: additive players in chronic liver disease?

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22392036

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Occult hepatitis B virus infection

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22392036

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S00430-011-0223-0

1 reference

6 December 2017

1 reference